To Evaluate the Role of Non - Invasive Ventilation in the Management of Type 2 Respiratory Failure - A Clinical Study

Type 2 respiratory failure, also known as hypercapnic respiratory failure, is characterized by elevated PaCO2 and reduced PaO2 levels, often arising from conditions like COPD, bronchial asthma, pneumonia, and ARDS. This study evaluates the efficacy of non - invasive ventilation (NIV), particularly BiPAP, in managing acute type 2 respiratory failure in 120 patients at PRS Hospital, Trivandrum. Key findings reveal an 83.3% improvement rate with significant reductions in PaCO2, stabilization of pH, and enhanced oxygenation (SpO2). Most patients responded well to NIV, with COPD being the most prevalent condition. The study underscores the importance of tailored NIV protocols based on diagnosis and highlights the need for continuous monitoring of arterial blood gases (ABG) to optimize treatment. While NIV proved effective in most cases, a 16.7% failure rate was observed, suggesting the need for alternative strategies for certain patients. These findings support NIV as a critical intervention for managing type 2 respiratory failure, emphasizing its role in reducing intubation rates and improving patient outcomes.